Dr . Lim Keng Hua

Goh Ting Hui Angeline

Kidneys · Singapore

Dr Angeline Goh is a renal medicine specialist at Mount Elizabeth Hospital, Singapore. She subspecialises in kidney transplantation. She also cares for conditions related to kidney diseases, such as hypertension, diabetes mellitus and urinary tract infections. Dr Goh has more than 20 years of experience in clinical medicine. She is well-versed in the use of immunosuppressants, and has spent over a decade caring for kidney transplant recipients and donors. Having cared for more than 400 prevalent kidney transplant recipients, she understands the need for regular monitoring to keep transplant recipients in good health. Prior to starting private practice, Dr Goh was a senior consultant nephrologist and transplant physician at the National University Hospital (NUH), where she was in charge of the Living Donor Kidney Transplant (LDKT) programme. Under her leadership, more than 100 new living donor kidney transplants have been performed in the National University Centre for Organ Transplantation from 2013 – 2019. Dr Goh underwent advanced specialty training in renal medicine at the Singapore General Hospital (SGH), and became an associate consultant in 2007. The importance of maintaining good kidney function after a transplant has led her to further develop preventive nephrology in her practice. Preventive nephrology is about preventing kidney failure, and is done through identification of urinary abnormalities such as blood or protein in the urine, and diagnosis of diabetes and hypertension. She has developed her own programme to monitor and advise patients on how best to maintain good kidney function to ensure good overall health. She strongly believes that good kidney function is a prerequisite for a healthy life. Dr Goh was a former assistant professor in the Yong Loo Lin School of Medicine, NUS, and external lecturer for the School of Health Sciences, Nanyang Polytechnic. She was formerly in charge of the overall teaching schedule for renal medicine trainees in SGH, and was core faculty in charge of transplant teaching for the Nephrology Senior Residency Programme in NUH. She helped to train fellows from the International Society of Nephrology from Bangladesh, Myanmar, and Brunei, as part of the development of the Transplant Programme in regional countries. Dr Goh has been actively involved in research in kidney transplantation and has presented in regional and international conferences. She was awarded a Poster of Distinction at the American Transplant Congress in 2009 for her work, “Survival of Second Liver Allografts is Influenced by Anti-HLA Class I Antibodies”, and has published her research in local and international medical journals.

Kua Jieli

Heart · Singapore

Dr Kua Jieli is a cardiologist at Mount Elizabeth Hospital, Singapore. His specialty is interventional cardiology. He was previously a senior consultant at the National University Heart Centre and Ng Teng Fong Hospital in Singapore, where he led the post-myocardial infarction (heart attack) clinic. He is currently a visiting consultant at the National University Health System. Dr Kua graduated from the National University of Singapore (NUS). He was awarded the Academic Medicine Development Award and completed advanced training in interventional cardiology at Hammersmith Hospital, UK. He gained experience in complex procedures while kept updated with the latest research. Thereafter, he was elected as a fellow and honorary consultant at Hammersmith Hospital Imperial Healthcare Trust, UK. He has been practising medicine for more than 15 years. He has performed over 5,000 invasive coronary angiographies and percutaneous coronary interventions. Dr Kua has also managed complex cardiovascular cases including left main disease, chronic total occlusions and calcified lesions. Dr Kua was elected fellow of both the Royal College of Physicians, UK and the Asian-Pacific Society of Interventional Cardiology. He is also an active member of the Western STEMI regional network committee and serves as the secretary for the PCI chapter of the Singapore Cardiac Society. Besides his clinical work, he is a clinical lecturer at NUS. His research has been published in numerous per-reviewed journals such as the European Journal of Cardiothoracic Surgery and the European Heart Journal. Additionally, his findings have been showcased at conferences like the Transcatheter Cardiovascular Therapeutics, where he has also received awards for his contributions.

Wong Siew Wei

Cancer · Singapore

Dr Wong Siew Wei is a medical oncologist at Gleneagles Hospital. His areas of expertise and interests are in prostate, kidney, bladder, upper gastrointestinal and lung cancers. Prior to private practice, Dr Wong was a consultant medical oncologist at Johns Hopkins Singapore International Medical Centre (JHSIMC) and Tan Tock Seng Hospital (TTSH). He was also a visiting consultant medical oncologist for the National Healthcare Group (NHG). He graduated from the University of Melbourne, Australia and then underwent training in medical oncology in Victoria, Australia, culminating in a fellowship in the Royal Australasian College of Physicians. Dr Wong holds a clinical diploma in palliative care from the Victorian Chapter of Palliative Medicine, Australia. While at JHSIMC and TTSH, Dr Wong was involved in multidisciplinary tumour boards in gastrointestinal, thoracic and genitourinary malignancies, and led a number of clinical trials. He has also been an invited speaker regionally. Besides his clinical work, he was the programme director of NHG’s medical oncology training programme. He also served as a member of TTSH’s drug and therapeutics committee. Dr Wong was a clinical teacher at the Lee Kong Chian School of Medicine at Nanyang Technological University. He has lectured at various oncology meetings at both national and regional levels, especially on the topic of genitourinary cancers, and given several public talks on cancer awareness.

Lee Yuh Shan

Blood · Singapore

Dr Lee Yuh Shan is a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore. He specialises in malignant haematology such as lymphoma, leukaemia, myeloma and haematopoietic stem cells transplant. He developed his specialty in lymphoma at the National Institutes of Health (NIH) in Maryland, United States, where he had first-hand experience in seeing patients under clinical trial with new oral therapy in the treatment of chronic lymphocytic leukemia (CLL) and aggressive lymphoma. He contributed to the development and incorporation of new agents in the treatment of lymphoma, as well as the development of investigator-initiated trials for aggressive lymphoma in the department of haematology at the Singapore General Hospital (SGH). Dr Lee worked for 10 years at SGH. He was the director of the lymphoma service in their department of haematology from 2017, and was the lymphoma lead at the SingHealth Duke Blood Cancer Centre (SDBCC) from 2018. He is active in collaborative works locally under the SDBCC and Singapore Lymphoma Working Group, as well as regionally for CLL. In addition, he is involved in many pharmaceutical sponsored trials and investigator-initiated trials, most of which focus on new agents in lymphoma and myeloma. Dr Lee is active in undergraduate medical training. He is a senior clinical tutor for the Yong Loo Lin School of Medicine at NUS, and is an adjunct associate professor at the Duke-NUS Medical School. He is also a faculty member of the senior residency programme in haematology at SGH. He is an active speaker at regional haematology symposiums especially in CLL/lymphoma. He also contributes to lymphoma support group and Singapore World Lymphoma Day. He has published in many peer-reviewed journals and is a reviewer for peer-reviewed journals. He is also a member of SingHealth Institutional Review Board (IRB) and sat on several pharmaceutical advisory boards.